# Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease

> **NCT07722650** · NA · COMPLETED · sponsor: **Instituto Internacional de Medicina y Terapia (IIMET)** · enrollment: 120 (actual)

## Conditions studied

- Dry Eye Syndrome (DES)
- Ocular Surface Disease

## Interventions

- **DRUG:** Systane Complete
- **DRUG:** Thealoz Duo

## Key facts

- **NCT ID:** NCT07722650
- **Lead sponsor:** Instituto Internacional de Medicina y Terapia (IIMET)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-06
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-07-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722650, "Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*